Has anyone heard anything regarding the timing of the release of the Phase 1 Pharmacokinetic study results? This is required before they launch in the Phase II Trial which is supposed to launch this quarter. 

It would be also interested to hear last year's financial results, especially the Cortalex sales numbers.